Inventiva (IVA) Short term Debt (2018 - 2025)
Inventiva (IVA) recorded quarterly Short term Debt of $54.0 million in Q2 2025, up 11.78% quarter-over-quarter from $48.3 million in Q4 2024, and up 17.94% on a YoY basis from $45.8 million in Q2 2024.
Inventiva (IVA) Short term Debt (2018 - 2025) Analysis & Trends
Inventiva's Short term Debt history runs 8 years deep, the most recent figure standing at $54.0 million for Q2 2025.
- In Q2 2025, Short term Debt rose 17.94% year-over-year to $54.0 million; the TTM figure through Jun 2025 stood at $54.0 million (up 17.94% YoY), while the FY2024 annual figure was $48.3 million, up 64.99% from the prior year.
- Short term Debt was $54.0 million for Q2 2025 at Inventiva, up from $48.3 million in the prior quarter.
- In the past five years, Short term Debt ranged from a high of $54.0 million in Q2 2025 to a low of $1.5 million in Q4 2021.
- Historically, Short term Debt has averaged $34.3 million across 5 years, with a median of $30.8 million in 2023.
- The sharpest annual moves came in 2021 and 2023: Short term Debt surged 6733.59% in 2021, then fell 3.36% in 2023.
- A 5-year view of Short term Debt shows it stood at $1.5 million in 2021, then surged by 1965.37% to $30.3 million in 2022, then retreated by 3.36% to $29.3 million in 2023, then soared by 64.99% to $48.3 million in 2024, then grew by 11.78% to $54.0 million in 2025.
- The last three Short term Debt figures came in at $54.0 million (Q2 2025), $48.3 million (Q4 2024), and $45.8 million (Q2 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - |
| 10 | Inventiva | 8.93 Mn | -259.80 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 53.99 Mn |
| Dec 31, 2024 | 48.30 Mn |
| Jun 30, 2024 | 45.78 Mn |
| Dec 31, 2023 | 29.27 Mn |
| Jun 30, 2023 | 30.76 Mn |
| Dec 31, 2022 | 30.29 Mn |
| Dec 31, 2021 | 1.47 Mn |
| Dec 31, 2020 | 21,461.22 |
| Dec 31, 2019 | 125,078.31 |
| Dec 31, 2018 | 172,350.86 |